Table 3.
Average concentrations of urinary metabolites and wristband analytes over the course of the study.
| Urinary metabolite (ng/mL)a | Mothers (n = 96) |
Children (n = 90) |
||||||||||
| Percentiles |
Percentiles |
|||||||||||
| MDLb | # (%) < MDLb. c | 25th | 50th | 75th | Max | MDLb | # (%) < MDLb,c | 25th | 50th | 75th | Max | |
| BC1PP | 0.15 | 15 (16) | 0.3 | 0.7 | 1.5 | 13.9 | 0.15 | 8 (9) | 0.3 | 0.9 | 2.3 | 17.1 |
| DPHP | 0.45 | – | 1.6 | 2.5 | 4.2 | 39.8 | 0.45 | – | 2.0 | 3.2 | 6.7 | 74.7 |
| BDC1PP | 0.19 | – | 0.6 | 1.1 | 2.2 | 7.8 | 0.19 | – | 1.2 | 2.6 | 5.4 | 40.4 |
| BC1PH1PP | 0.64 | 2 (2) | 0.5 | 0.9 | 1.5 | 6.9 | 0.64 | 4 (5) | 0.4 | 0.6 | 1.0 | 4.2 |
| ip-DPHP | 0.08 | – | 4.2 | 6.7 | 10.9 | 46.0 | 0.08 | – | 5.0 | 7.7 | 12.0 | 46.7 |
| tbutyl-DPHP | 0.08 | 2 (2) | 0.2 | 0.2 | 0.4 | 1.8 | 0.08 | 1 (1) | 0.2 | 0.3 | 0.5 | 2.7 |
| Mothers (n = 38) |
Children (n = 38) |
|||||||||||
| Percentiles |
Percentiles |
|||||||||||
| Wristband analyte (ng/g) | LODc | # (%) < LODd, e | 25th | 50th | 75th | Max | LODc | # (%) < LODd, e | 25th | 50th | 75th | Max |
| TCEP | 3.27 | 4 (11) | 68.3 | 108.5 | 173.0 | 719 | 3.83 | 9 (24) | 31.7 | 64.5 | 115.0 | 656 |
| TCIPP | 5.12 | 21 (55) | 3.6 | 4.2 | 252.0 | 929 | 6.00 | 10 (26) | 4.2 | 297.5 | 778.0 | 3490 |
| TDCIPP | 5.00 | 1 (3) | 85.6 | 163.5 | 352.0 | 1060 | 5.85 | 1 (3) | 135.0 | 390.5 | 658.0 | 2460 |
| TPHP | 0.72 | – | 166.0 | 399.0 | 529.0 | 2230 | 0.72 | – | 195.0 | 440.0 | 976.0 | 3050 |
Urinary metabolites are normalized to specific gravity.
MDL = method detection limit of the analyte; # (%) < MDL = number and percentage of participants with concentrations below the MDL.
Percent calculated is # < MDL divided by 96 for mothers and by 90 for children.
LOD = method detection limit of the analyte; # (%) < LOD = number and percentage of participants with concentrations below the LOD.
Percent calculated is # < LOD divided by 38 for mothers and for children.